❌

Reading view

There are new articles available, click to refresh the page.

New Covid Vaccine Endorsed for Fall

The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.

Β© Jamie Kelter Davis for The New York Times

Studies have shown that protection against serious illness from Covid-19 tends to improve as the vaccines more precisely target dominant strains, according to the Food and Drug Administration.

FDA Panel Rejects Use of MDMA for Treatment of PTSD

An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Β© Travis Dove for The New York Times

A dose of MDMA from the MAPS Public Benefit Corp., which is now renamed as Lykos Therapeutics, a for-profit company whose studies the F.D.A. is analyzing.

What Is MDMA Therapy for PTSD? And What Are Its Risks?

An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws.

Β© Kenzo Tribouillard/Agence France-Presse β€” Getty Images

Developed in 1912, MDMA was reclassified in 1985 as a Schedule I substance, a drug defined as having no accepted medical use and a high potential for abuse.

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

Β© Noel Celis/Agence France-Presse β€” Getty Images

A seizure of the drug MDMA, known as Ecstasy or molly. It and other psychoactive drugs are still classified as illegal drugs with a potential for abuse.
❌